MVŽ1 - Anti-cancer ovarian and uterine examination program - The program consists of the main cancer markers that increase in ovarian or uterine cancer. PS: These cancer signs cannot be used for prophylaxis. Cancer markers are used to correct diagnosis and monitor the course of cancer treatment.
MVŽ2 - Antitumor extended ovarian and uterine examination program - The program consists of cancer markers, which usually increase with ovarian and uterine cancer. PS: These cancer signs cannot be used for prophylaxis. Cancer markers are used to correct diagnosis and monitor the course of cancer treatment.
MVŽ3 - Anti-Cancer Breast Examination Program - A program for breast cancer testing that consists of cancer markers that increase with breast cancer. PS: These cancer signs cannot be used for prophylaxis. Cancer markers are used to correct diagnosis and monitor the course of cancer treatment.
MVZ4 - Cervical screening program - Cervical cancer prevention program, which consists of the highest quality liquid media technology in cervical cells research and a particularly accurate human papillomavirus study. Malignant types of human papillomavirus are the main cause of cervical cancer.
| MVŽ1 68 € |
MVŽ2 80 € |
MVŽ3 20 € |
MVŽ4 80 € |
|
| CA 125 (ovarian cancer marker) | + | + | ||
| CA 19-9 (pancreatic cancer marker) | + | + | ||
| CA 15-3 (breast cancer marker) | + | |||
| CEA (carcinoembryonic antigen) | + | + | + | |
| HE-4 | + | + | ||
| ROMA index | + | + | ||
| α-Fetoprotein (AFP) | + | |||
| Chorionic gonadotropin (HCG) | + | |||
| ThinPrep liquid cytological assay | + | |||
| HPV 16, 18 with high risk genotyping selection | + | |||
| (PSA) | ||||
| Free PSA |
